Updated April 19 at 1:08am
Biotechnology
40 results total, viewing 21 - 30
A Japanese biopharmaceutical company has contracted to begin using a protein-screening interface developed by Providence-based EpiVax Inc. more
MassChallenge, a startup accelerator program, awarded $1.75 million at its annual startup awards ceremony Wednesday, the Boston Business Journal reported. more
Nabsys Inc. has named Tony Shuber vice president and chief scientific officer in its latest move toward bringing its genome-mapping products to market. more
The co-founder and president of MedMates, Rhode Island’s first health care technology network group, and co-founder and director of an emerging health-tech company, Aspiera Medical, talks about starting a company in Rhode Island and what he expects MedMates to look like down the road. more
An investor in two large Bay State health care companies involved in separate mergers said he doesn’t expect the U.S. Treasury’s recently announced measures aimed at cracking down on corporate tax inversions to derail those plans, the Boston Business Journal reported. more
Steve Lombardi has been named CEO and president of Nabsys Inc., a life sciences company pioneering semiconductor-based tools for genomic analysis. more
NsGene Inc.’s innovative brain-repair therapy couldn’t have come at a better time, as one of the neurodegenerative diseases it would treat – Parkinson’s disease – has gotten a lot of press lately. more
Dr. Anne S. De Groot, EpiVax CEO and University of Rhode Island professor, has been named one of the most influential people in the vaccine industry by the national vaccine industry organization VaccineNation. more
MultiCell Technologies Inc. has been issued a U.S. patent for drug compositions and platform technologies, which are designed treat virus infections and cancer. more
Tech Collective, Rhode Island’s bioscience and IT industry association, has announced the four winners of its second annual Rhode Island Bioscience Awards. more
« Prev | 1 | 2 | 3 | 4 Next »